Aug 05, 2022 / 10:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Eris Lifesciences Limited Q1 FY '23 Earnings Conference Call. We have with us on the call today Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. V Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.
Krishnakumar Vaidyanathan - Eris Lifesciences Limited - Executive Director & COO
Thank you. Good afternoon, and welcome to our conference call for the first quarter of financial year '23. I'm Krishnakumar, and I'll be sharing the highlights of the quarter with you. I'm happy to open the call by sharing that our Zomelis Mother Brand has hit a monthly run rate of INR 100 crores per annum on a monthly sales basis in just 2.5 years from acquisition. This represents a growth of more than 8x in monthly sales since acquisition. So when we acquired this brand, it was doing a monthly
Q1 2023 Eris Lifesciences Ltd Earnings Call Transcript
Aug 05, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers